Viewing nowLipien Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201500649 · Approved 2015.02.06 · Insurance code 628900450
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication is mainly used in the treatment of cardiovascular diseases and hyperlipidemia. It helps reduce the risk of myocardial infarction, stroke, the need for vascular revascularization, angina, and hospitalization due to congestive heart failure in adult patients with multiple risk factors for cardiovascular disease. It also has a preventive effect against cardiovascular complications in patients with type 2 diabetes mellitus. In the treatment of hyperlipidemia, it improves the dyslipidemia levels in patients with primary hypercholesterolemia and mixed dyslipidemia and is used as an adjunct in cases where sufficient effect cannot be achieved with diet therapy. Particularly, it is effective in lowering total cholesterol and LDL-cholesterol levels in pediatric patients aged between 10 and 17 years with heterozygous familial hypercholesterolemia. This medication is used to reduce the risk of cardiovascular disease and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at treatment initiation and to assess treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: The dosage of this medication is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients).
This medication must be stopped immediately if any unusual muscle symptoms occur. Muscle pain or weakness can progress to a serious condition called rhabdomyolysis, so caution is required. This medication can affect liver function, thus should not be used in patients with liver disease or impaired liver function. Additionally, pregnant women or those who may become pregnant, as well as breastfeeding women, should not take this medication. Children under the age of 10 should not use this medication, and careful use is required for children aged 10 to 17 years under the direction of a physician. This medication may interact with certain drugs taken together, so if taking other medications, it is essential to inform a healthcare provider or pharmacist. In particular, the risk of muscle abnormalities may increase when used with medications that inhibit enzymes that break down drugs in the liver. During use, if symptoms such as muscle pain, fatigue, malaise, or fever occur, it is crucial to inform a healthcare professional immediately and undergo tests. Regular liver function tests and blood tests to check for abnormalities are also important. This medication may increase drug concentration if taken with grapefruit juice; hence, it is advisable to avoid grapefruit juice intake. Elderly or patients with impaired kidney function are at a higher risk for muscle abnormalities, requiring closer monitoring and potential adjustments in medication dosage. Finally, this medication should be kept out of reach of children and stored securely in its original container with the seal intact.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It should be stored at room temperature, ideally between 1 to 30 degrees Celsius, avoiding extremes of temperature.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.